|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.24/-0.69
|
企业价值
186.67M
|
资产负债 |
每股账面净值
0.13
|
现金流量 |
现金流量率
--
|
损益表 |
收益
1.33M
|
每股收益
0.02
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/21 11:34 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others. |